Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 2.

Clinical Characteristics of the Subjects According to Gastroesophageal Reflux Disease

Variables OSA (N = 318) P-value

GERD (+)
(n = 41)
GERD (–)
(n = 277)
Age (yr) 52.1 ± 11.2 50.7 ± 12.8 0.518
Sex 0.831
Men 30 (73.2) 207 (74.7)
Women 11 (26.8) 70 (25.3)
Hypertension 13 (31.71) 92 (33.2) 0.848
DM 8 (19.51) 35 (12.6) 0.229
Alcohol 22 (53.0) 173 (62.5) 0.365
Smoking 0.703
Never 22 (53.7) 139 (50.2)
Current 9 (22.0) 53 (19.1)
Ex-smoker 10 (24.4) 85 (30.7)
Aspirin 4 (9.8) 49 (17.8) 0.200
NSAIDs 2 (4.9) 20 (6.3) 0.751
Anti-anxiety drug 3 (7.3) 17 (6.2) 0.732
PPI 9 (22.0) 20 (7.3) 0.006a
BMI (kg/m2) 28.1 ± 4.4 27.0 ± 4.3 0.117
WHR 0.58 ± 0.07 0.57 ± 0.06 0.128
WHI (cm/m2) 35.52 ± 5.12 34.19 ± 4.60 0.102
SSS score 3.00 ± 1.22 2.48 ± 1.03 0.004a
ESS score 11.71 ± 4.91 9.16 ± 3.83 0.001a
HADS
Anxiety score 5.20 ± 4.00 4.62 ± 3.72 0.454
Depression score 8.05 ± 3.75 5.68 ± 3.54 < 0.001a

aP < 0.05: statistical significance.

OSA, obstructive sleep apnea; GERD, gastroesophageal reflux disease; DM, diabetes mellitus; PPI, proton pump inhibitor; BMI, body mass index; WHR, waist-to-height ratio; WHI, waist circumference-to-height index; SSS, Stanford Sleepiness Scale; ESS, Epworth Sleepiness Scale; HADS, Hospital Anxiety and Depression Scale.

Data are presented as mean ± SD or n (%).

J Neurogastroenterol Motil 2021;27:215~222 https://doi.org/10.5056/jnm20071
© J Neurogastroenterol Motil